Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Bioorg Med Chem. 2017 Nov 4;26(1):25–36. doi: 10.1016/j.bmc.2017.10.042

Figure 4. Quantification of c-MYC protein levels.

Figure 4

HD-MB03 medulloblastoma cells (nuclei in blue) were treated with either DMSO, or increasing concentrations of compound 9, then fixed and stained for c-MYC expression after 72 hours. Immunofluorescence with an antibody against c-MYC shows decreased levels of the protein (green) with increasing concentration of compound when compared to the DMSO control. Images acquired at 10x.